No previous suggestions found.

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

1
Home
Companies

Invitae

#8494

Rank

$5.59M

Marketcap

US United States

Country

Invitae
Leadership team

Mr. Kenneth D. Knight (Pres, CEO & Director)

Ms. Yafei Wen (Chief Financial Officer)

Mr. Thomas R. Brida (Gen. Counsel, Chief Compliance Officer & Sec.)

Products/ Services
Biotechnology, Genetics, Health Care
Number of Employees
1,000 - 20,000
Headquarters
San Francisco, California, United States
Established
2010
Company Registration
SEC CIK number: 0001501134
Revenue
500M - 1B
Traded as
NVTA
Social Media
URL
https://www.invitae.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
History

Invitae was founded in 2012 by Sean George and Randy Scott and is based in San Francisco, California. In its first years, Invitae focused on building its technology infrastructure and expanding its clinical laboratory. 2012 also saw the launch of Invitae's hereditary cancer testing service.

Mission
At Invitae, we strive to make genetics accessible to everyone by providing comprehensive, affordable and accessible genetic testing and information services.
Vision
Invitae believes that the power of genetics can lead to the prevention, diagnosis and treatment of the world’s most devastating diseases.
Key Team

Dr. Robert L. Nussbaum M.D. (Chief Medical Officer)

Ms. Shelly D. Guyer (Chief Sustainability Officer)

Mr. Robert F. Werner (Chief Accounting Officer & Principal Accounting Officer)

Ms. Hoki Luk (Head of Investor Relations and Capital Markets)

Mr. Lee Bendekgey J.D. (Chief Policy Officer)

Glenn Medalle (Head of Talent)

Ms. Desarie French (Chief Talent Officer)

Recognition and Awards
Invitae has been honored with numerous awards for its innovation and revolutionary approach to transforming healthcare with genetics.
References

https://en.wikipedia.org/wiki/Invitae

https://in.investing.com/equities/invitae-corp

https://www.comparably.com/companies/invitae/mission

https://www.crunchbase.com/organization/invitae-corporation

https://finance.yahoo.com/quote/NVTA/

https://www.invitae.com

https://sec.report/CIK/0001501134

Invitae
Leadership team

Mr. Kenneth D. Knight (Pres, CEO & Director)

Ms. Yafei Wen (Chief Financial Officer)

Mr. Thomas R. Brida (Gen. Counsel, Chief Compliance Officer & Sec.)

Products/ Services
Biotechnology, Genetics, Health Care
Number of Employees
1,000 - 20,000
Headquarters
San Francisco, California, United States
Established
2010
Company Registration
SEC CIK number: 0001501134
Revenue
500M - 1B
Traded as
NVTA
Social Media
URL
https://www.invitae.com
About

Businessabc provides a digital business directory, resources, a marketplace, and a digital blockchain AI certification for businesses, organisations, and professionals.

contacts

businessabc@ztudium.com

Follow Us
Produced by
In collaboration with
Logo

Copyright 2024 © Businessabc powered by ztudium

Privacy Policy